OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	115
The deltoid muscle and the pattern of paresis in ALS	114
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	111
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	110
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	105
Richard Caton (1842-1926)	99
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective	94
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	92
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	86
Explaining recovery from coma with multimodal neuroimaging	83
Tacrolimus-induced Parkinsonism	82
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	79
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	78
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	68
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	63
Neurological manifestation of HEV infection: still a rare disease entity?	63
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	60
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	60
The DeMyers: Marian (1922–2012) and William (1924–2008)	58
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	57
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	55
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	55
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	55
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	53
Tourette syndrome: effects of acetyl-leucine in two individuals	53

Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	53
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	52
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	51
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	50
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	50
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	49
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	48
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	48
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	48
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	47
Natalizumab-induced pneumonitis	46
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	46
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	46
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	46
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	45
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson’s disease: a systematic review and meta-analysis	45
Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy	45
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	44
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	43
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	43